查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1827696

2025年3D生物列印全球市场报告

3D Bioprinting Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，3D生物列印市场快速扩张，市场规模从2024年的18.6亿美元成长到2025年的21.9亿美元，复合年增长率达18.2%。预测期内的成长归因于研发资金的增加、慢性病的增加、器官短缺、药物检测的增加以及组织工程的发展。

预计未来几年，3D生物列印市场规模将呈指数级增长，到2029年将达到50.4亿美元，复合年增长率为23.1%。预测期内的增长可归因于医疗保健的进步、生物打印皮肤的蓬勃发展、患者意识的提升以及人口老化。预测期内的主要趋势包括多材料列印、血管生成技术、器官晶片、客製化植入以及太空生物製造。

3D生物列印是一种积层製造技术，它可以逐层列印出模拟生物系统行为的活体结构。该技术利用细胞和生物相容性材料，通常称为生物墨水。 3D生物列印材料的主要应用领域是药物研究，以及近期用于建造细胞骨架以修復受损的韧带和关节。

3D生物列印的关键组件是3D生物列印机和生物墨水。 3D生物列印机采用三维技术，利用生物相容性材料复製各种身体部位，进而实现组织、骨骼、器官、血管和生物医学组件的生物列印。此过程涉及的材料包括活细胞、水凝胶和细胞外基质。 3D生物列印在研究和临床领域有着广泛的应用，并正在研究机构、学术机构、生物製药公司和医院等多个领域开展应用。

2025年春季美国关税的突然上调及其引发的贸易摩擦对医疗设备行业产生了重大影响，尤其对用于诊断影像设备的进口零件、手术用不銹钢和一次性塑胶製品产生了重大影响。由于医院和诊所抵制价格上涨，製造商面临利润压力。监管挑战使情况更加复杂，因为由于关税而更换供应商通常需要重新认证医疗设备，导致市场进入延迟。为此，企业正在透过双重采购关键零件、加强标准化产品的国内生产以及加快寻找更具成本效益的材料来降低风险。

本研究报告是商业研究公司 (The Business Research Company) 新报告系列的一部分，该系列提供 3D 生物列印市场统计数据，例如 3D 生物列印行业的全球市场规模、各地区市场份额、各竞争对手的市场份额、详细的 3D 生物列印行业细分市场、市场趋势和商机，以及您在 3D 生物列印行业取得成功所需的数据。本 3D 生物列印市场研究报告对该行业的现状和未来趋势进行了详细分析，为您提供所需的一切观点。

我们预测未来五年该市场将成长23.1%，较我们先前对该市场的预测略有下降0.2%。这一下降主要源自于美国与其他国家之间关税的影响。这将对美国产生直接影响，限制其获取瑞士生物墨水配方和德国精密挤出喷嘴，从而减缓其在组织工程应用方面的研究。此外，由于互惠关税以及贸易紧张局势和限制措施不断升级对全球经济和贸易的负面影响，这一影响也将更加广泛地显现出来。

预计在预测期内，支持 3D 生物列印研究活动的政府和私人资金不断增加将推动 3D 生物列印市场的成长。 3D 生物列印在医疗保健领域的应用日益广泛，吸引了政府和私人组织的资金。这笔资金包括对 3D 生物列印技术各个开发阶段的财务和技术支援。例如，2022 年 5 月，瑞士生物列印公司 Readily3d SA 从欧盟获得 60 万美元的资助，用于利用该公司的 Tomolite 3D 生物列印技术开发胰腺活体微型模型。澳洲卫生部长向科廷大学拨款 737,690 美元，用于开发和优化一种 3D 技术，将皮肤组织直接生物列印到模型伤口中，作为人体皮肤修復的先决条件。

慢性病的预期成长将推动3D生物列印市场的未来成长。由于慢性病通常持续超过三个月，并且往往是终生的，因此3D生物列印越来越多地被用于创建组织模型，以协助慢性病研究和潜在的器官替代疗法。例如，根据世界卫生组织（WHO）在2022年9月发布的报告，全球整体每年约有4,100万人死亡，占所有死亡人数的74%。这个惊人的数字包括1,790万人死于心血管疾病，930万人死于癌症，410万人死于慢性呼吸道疾病，200万人死于糖尿病。因此，慢性病的快速增加是3D生物列印市场成长的主要驱动力。

3D生物列印市场的主要企业正专注于开发用于组织工程和再生医学的下一代生物列印机。生物3D列印机是一种专用设备，它使用由活细胞和生物相容性材料製成的生物墨水来建造组织和器官等生物结构。例如，2022年11月，印度医疗保健公司Abbey Biosciences推出了MitoPlus。这款印表机有助于创建复杂的人体组织，解决了器官短缺和改善药物检测方法等关键问题。其主要特点包括精确的温度控制（4°C至80°C）、相容于多种生物材料的双挤出机系统、内置紫外线固化功能（可提高组织品质）以及高效能空气微粒子过滤器（HEPA），可保持列印环境的无菌。

3D 生物列印市场的主要企业正专注于开发创新技术解决方案，例如 3D 生物列印机，以提高组织工程和再生医学的精确度和效率。 3D 生物列印机利用含有活细胞的生物墨水来创建三维组织和器官结构，用于医学研究和再生医学应用。例如，2024 年 6 月，美国陶瓷粉末和金属聚合物产品开发商 Tethon 3D 推出 Bison Bio DLP 3D 生物列印机，进入生物列印市场。这款先进的印表机是与 Carima 合作开发的，提供可调的建造尺寸（30 x 20 毫米、57 x 32 毫米和 96 x 54 毫米），并与 Tethon 专有的 LAP 光光引发剂和 GelMA 水凝胶生物墨水相容，这对于生物列印活组织至关重要。 Bison Bio 的尺寸为 24 x 24 x 24 英寸，重 75 磅，售价为 19,950 美元，旨在透过创建用于生物医学研究的复杂组织和器官、支持个性化医疗和再生疗法来加速医疗保健的进步。

2022年5月，专注于3D生物列印技术的瑞典生技公司BICO宣布以600万美元收购Allegro 3D。此次收购旨在透过整合先进技术并扩大市场覆盖范围，支持BICO的策略目标。 Allegro 3D位于圣地牙哥，专注于基于光的列印技术，将增强BICO的现有实力。

3D 生物列印市场的主要企业包括 Organovo Holdings Inc.、Allevi Inc.、Cellink AB、Aspect Biosystems Ltd.、3D Systems Corporation、Cyfuse Biomedical KK、EnvisionTEC GmbH、Poietis SA、TeVido BioDevices、Nano3D Biosciences Inc.、Dirlab Inc.、Recidanced、Ftak 或t. BIoTechnology Co.Ltd.、Regemat 3D SL、Bio3D Technologies、Stratasys Ltd.、ROKIT Healthcare Co.Ltd.、Inventia Life Science Pvt。 Ltd.、Vivax Bio LLC、GE HealthCare Technologies Inc.、3D BIoTek LLC、Nuclera Nucleics Ltd.、3D Fortify Inc.、Carbon Inc.、Divergent Technologies Inc.、Markforged Inc.、SprintRay Inc.、3D Bio Corp、3D Bioprinting Solutions、BICO Group AB、Collat​​​​y Ltd.和 Modern Meadow Inc.

2024年，3D生物列印市场最大的地区将是北美。预计在预测期内，亚太地区将成为3D生物列印市场成长最快的地区。 3D生物列印市场报告涵盖以下地区：亚太地区、西欧、中欧和东欧、北美、南美以及中东和非洲。

3D生物列印市场报告涵盖的国家有澳洲、巴西、中国、法国、德国、印度、印尼、日本、俄罗斯、韩国、英国和美国。

3D生物列印市场包括挤出式生物列印、喷墨式生物列印、雷射辅助生物列印和立体光刻技术生物列印的销售。该市场的价值是指“出厂价”，即商品製造商或创造者销售给其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接销售给最终客户的价值。该市场中的商品价值还包括商品创造者销售的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球 3D 生物列印：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 最终用途产业分析
  • 全球3D生物列印市场：成长率分析
  • 全球3D生物列印市场表现：规模与成长，2019-2024年
  • 全球3D生物列印市场预测：规模与成长，2024-2029年，2034年
  • 全球 3D 生物列印：总目标市场 (TAM)

第六章 市场细分

  • 全球 3D 生物列印市场（按组件、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 3D生物列印机
  • 生物墨水
  • 全球 3D 生物列印市场（按材料、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 活细胞
  • 水凝胶
  • 细胞外基质
  • 其他的
  • 全球3D生物列印市场的应用、效能与预测（2019-2024年、2024-2029年、2034年）
  • 研究用途
  • 临床应用
  • 其他的
  • 全球 3D 生物列印市场（依最终用户划分）：2019-2024 年、2024-2029 年、2034 年业绩及预测
  • 研究和学术机构
  • 生物製药公司
  • 医院
  • 其他的
  • 全球 3D 生物列印市场：3D 生物列印机细分市场，按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 喷墨3D生物列印机
  • 微挤压3D生物列印机
  • 雷射辅助3D生物列印机
  • 立体光刻技术（SLA）生物印表机
  • 全球 3D 生物列印市场：生物墨水细分市场、类型、效能及预测（2019-2024 年、2024-2029 年、2034 年）
  • 天然生物墨水
  • 合成生物墨水
  • 混合生物墨水
  • 水凝胶

第七章 区域和国家分析

  • 全球3D生物列印市场：依地区、绩效及预测，2019-2024年、2024-2029年、2034年
  • 全球 3D 生物列印市场：国家、绩效与预测（2019-2024 年、2024-2029 年、2034 年）

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 3D生物列印市场：竞争格局
  • 3D生物列印市场：公司简介
    • Organovo Holdings Inc.
    • Allevi Inc.
    • Cellink AB
    • Aspect Biosystems Ltd.
    • 3D Systems Corporation

第31章：其他领先和创新企业

  • Cyfuse Biomedical KK
  • EnvisionTEC GmbH
  • Poietis SA
  • TeVido BioDevices
  • Nano3D Biosciences Inc.
  • Digilab Inc.
  • RegenHU Ltd.
  • GeSiM mbH
  • Advanced Solutions Life Sciences LLC
  • Regenovo BIoTechnology Co. Ltd.
  • Regemat 3D SL
  • Bio3D Technologies
  • Stratasys Ltd.
  • ROKIT Healthcare Co. Ltd.
  • Inventia Life Science Pvt. Ltd.

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第35章：市场潜力大的国家与策略

  • 2029年3D生物列印市场：提供新机会的国家
  • 2029年3D生物列印市场：细分领域带来新机会
  • 2029年3D生物列印市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r20918u

3D Bioprinting, a form of additive manufacturing, involves the layer-by-layer printing of live structures that emulate the behavior of living systems. This process utilizes cells and biocompatible materials, commonly referred to as bio-inks. The primary application of 3D bioprinting materials is in drug research, and more recently, in the creation of cell scaffolds for repairing damaged ligaments and joints.

The key components in 3D bioprinting include 3D bioprinters and bio-inks. 3D bioprinters employ three-dimensional technology along with biocompatible materials to replicate various body parts, facilitating the bioprinting of tissues, bones, organs, blood vessels, and biomedical components. The materials involved in the process encompass living cells, hydrogels, extracellular matrices, and others. The application of 3D bioprinting extends to research and clinical settings, among others, and finds implementation in diverse sectors such as research organizations, academic institutes, biopharmaceutical companies, hospitals, and more.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The 3D bioprinting market research report is one of a series of new reports from The Business Research Company that provides 3D bioprinting market statistics, including 3D bioprinting industry global market size, regional shares, competitors with a 3D bioprinting market share, detailed 3D bioprinting market segments, market trends and opportunities, and any further data you may need to thrive in the 3D bioprinting industry. This 3D bioprinting market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The 3D bioprinting market size has grown rapidly in recent years. It will grow from $1.86 billion in 2024 to $2.19 billion in 2025 at a compound annual growth rate (CAGR) of 18.2%. The growth in the historic period can be attributed to research and development funding, growth in chronic diseases, organ shortage, rise in pharmaceutical testing, growth in tissue engineering.

The 3D bioprinting market size is expected to see exponential growth in the next few years. It will grow to $5.04 billion in 2029 at a compound annual growth rate (CAGR) of 23.1%. The growth in the forecast period can be attributed to healthcare advancements, rising development of bioprinted skin, growing awareness among patients, aging population. Major trends in the forecast period include multi-material printing, vascularization techniques, organ-on-a-chip, custom implants, biofabrication in space.

The forecast of 23.1% growth over the next five years reflects a modest reduction of 0.2% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through restricted access to bioink formulations from Switzerland and precision extrusion nozzles from Germany, slowing research in tissue engineering applications.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Rising governments and private funding to support 3D bioprinting research activities are expected to drive the growth of the 3D bioprinting market in the forecast period. 3D bioprinting is increasing applications in healthcare attracted funding from government and private organizations. This funding provides financial and technical assistance across different development phases of 3D bioprinting techniques. For instance, in May 2022, Readily3d SA, a Switzerland-based bioprinting company, received funding of $600,000 from the European Union to develop a living miniature model of the pancreas using its Tomolite 3D bioprinting technique. The Australian Minister for Health funded Curtin University with $737,690 to develop and optimize 3D technology for bioprinting skin tissue directly onto model wounds as a prelude to human skin restoration

The anticipated rise in chronic diseases is set to be a driving factor in the prospective growth of the 3D bioprinting market. Chronic diseases, persisting over extended periods-typically three months or more, and often for a person's lifetime-have increasingly utilized 3D bioprinting for creating tissue models, aiding in chronic disease research and potential organ replacement therapies. For example, as per the World Health Organization's September 2022 report, approximately 41 million deaths globally annually, representing 74% of fatalities, are attributed to non-communicable diseases (NCDs) or chronic diseases. This alarming figure includes 17.9 million deaths from cardiovascular diseases, 9.3 million deaths from cancer, 4.1 million deaths from chronic respiratory diseases, and 2.0 million deaths from diabetes. Consequently, the upsurge in chronic diseases is a significant driver behind the growth of the 3D bioprinting market.

Leading companies in the 3D bioprinting market are focusing on developing next-generation bioprinters for use in tissue engineering and regenerative medicine. A bio 3D printer is a specialized device that constructs biological structures, such as tissues and organs, using bioinks made from living cells or biocompatible materials. For example, in November 2022, Avay Biosciences, an India-based healthcare company, launched the Mito Plus. This printer facilitates the creation of complex human tissues, addressing critical challenges like organ shortages and improving drug testing methodologies. Key features include precise temperature control (ranging from 4°C to 80°C), a dual-extruder system for multiple biomaterials, inbuilt UV curing to enhance tissue quality, and HEPA filters to maintain a sterile printing environment

Major companies in the 3D bioprinting market are focusing on developing innovative technological solutions, such as 3D bioprinters, to improve precision and efficiency in tissue engineering and regenerative medicine. 3D bioprinters are devices that utilize bioinks containing living cells to produce three-dimensional tissue and organ structures for medical research and regenerative medicine applications. For example, in June 2024, Tethon 3D, a US-based developer of ceramic powder and metal-polymer products, introduced the Bison Bio DLP 3D bioprinter, marking its entry into the bioprinting market. Developed in collaboration with Carima, this advanced printer offers adjustable build sizes (30 X 20 mm, 57 X 32 mm, and 96 X 54 mm) and is compatible with Tethon's proprietary LAP photoinitiator and GelMA hydrogel bioink, crucial for bioprinting living tissues. Measuring 24 X 24 X 24 inches and weighing 75 lbs, the Bison Bio is priced at $19,950 and aims to drive advancements in healthcare by enabling the creation of complex tissues and organs for biomedical research, supporting personalized medicine and regenerative therapies

In May 2022, BICO, a biotechnology company from Sweden focused on 3D bioprinting technology, announced the acquisition of Allegro 3D, Inc. for $6 million. This acquisition is intended to support BICO's strategic objectives by incorporating advanced technology and broadening its market reach. Allegro 3D, Inc., located in San Diego, specializes in light-based printing technology, which enhances BICO's current capabilities.

Major companies operating in the 3D bioprinting market include Organovo Holdings Inc., Allevi Inc., Cellink AB, Aspect Biosystems Ltd., 3D Systems Corporation, Cyfuse Biomedical KK, EnvisionTEC GmbH, Poietis SA, TeVido BioDevices, Nano3D Biosciences Inc., Digilab Inc., RegenHU Ltd., GeSiM mbH, Advanced Solutions Life Sciences LLC, Regenovo Biotechnology Co. Ltd., Regemat 3D S.L., Bio3D Technologies, Stratasys Ltd., ROKIT Healthcare Co. Ltd., Inventia Life Science Pvt. Ltd., Vivax Bio LLC, GE HealthCare Technologies Inc., 3D Biotek LLC, Nuclera Nucleics Ltd., 3D Fortify Inc., Carbon Inc., Divergent Technologies Inc., Markforged Inc., SprintRay Inc., 3D Bio Corp, 3D Bioprinting Solutions, BICO Group AB, CollPlant Biotechnologies Ltd., Shining 3D Tech Co. Ltd., 3Dynamic Systems Ltd., Modern Meadow Inc.

North America was the largest region in the 3D bioprinting market in 2024. The Asia-Pacific is expected to be the fastest-growing region in the 3D bioprinting market during the forecast period. The regions covered in the 3D bioprinting market report analysis are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The countries covered in the 3D bioprinting market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The 3D bioprinting market consists of sales of extrusion-based bioprinting, inkjet-based bioprinting, laser-assisted bioprinting, and stereolithography bioprinting. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

3D Bioprinting Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on 3d bioprinting market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for 3d bioprinting ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The 3d bioprinting market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Component: 3D Bioprinters; Bioinks
  • 2) By Material: Living Cells; Hydrogels; Extracellular Matrices; Other Materials
  • 3) By Application: Research Applications; Clinical Application; Other Applications
  • 4) By End User: Research Organization And Academic Institutes; Biopharmaceuticals Companies; Hospitals; Other End Users
  • Subsegments:
  • 1) By 3D Bioprinters: Inkjet 3D Bioprinters; Microextrusion 3D Bioprinters; Laser-Assisted 3D Bioprinters; Stereolithography (SLA) Bioprinters
  • 2) By Bioinks: Natural Bioinks; Synthetic Bioinks; Hybrid Bioinks; Hydrogels
  • Companies Mentioned: Organovo Holdings Inc.; Allevi Inc.; Cellink AB; Aspect Biosystems Ltd.; 3D Systems Corporation; Cyfuse Biomedical KK; EnvisionTEC GmbH; Poietis SA; TeVido BioDevices; Nano3D Biosciences Inc.; Digilab Inc.; RegenHU Ltd.; GeSiM mbH; Advanced Solutions Life Sciences LLC; Regenovo Biotechnology Co. Ltd.; Regemat 3D S.L.; Bio3D Technologies; Stratasys Ltd.; ROKIT Healthcare Co. Ltd.; Inventia Life Science Pvt. Ltd.; Vivax Bio LLC; GE HealthCare Technologies Inc.; 3D Biotek LLC; Nuclera Nucleics Ltd.; 3D Fortify Inc.; Carbon Inc.; Divergent Technologies Inc.; Markforged Inc.; SprintRay Inc.; 3D Bio Corp; 3D Bioprinting Solutions; BICO Group AB; CollPlant Biotechnologies Ltd.; Shining 3D Tech Co. Ltd.; 3Dynamic Systems Ltd.; Modern Meadow Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. 3D Bioprinting Market Characteristics

3. 3D Bioprinting Market Trends And Strategies

4. 3D Bioprinting Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global 3D Bioprinting Growth Analysis And Strategic Analysis Framework

  • 5.1. Global 3D Bioprinting PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global 3D Bioprinting Market Growth Rate Analysis
  • 5.4. Global 3D Bioprinting Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global 3D Bioprinting Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global 3D Bioprinting Total Addressable Market (TAM)

6. 3D Bioprinting Market Segmentation

  • 6.1. Global 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 3D Bioprinters
  • Bioinks
  • 6.2. Global 3D Bioprinting Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Living Cells
  • Hydrogels
  • Extracellular Matrices
  • Other Materials
  • 6.3. Global 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Research Applications
  • Clinical Application
  • Other Applications
  • 6.4. Global 3D Bioprinting Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Research Organization And Academic Institutes
  • Biopharmaceuticals Companies
  • Hospitals
  • Other End Users
  • 6.5. Global 3D Bioprinting Market, Sub-Segmentation Of 3D Bioprinters, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Inkjet 3D Bioprinters
  • Microextrusion 3D Bioprinters
  • Laser-Assisted 3D Bioprinters
  • Stereolithography (SLA) Bioprinters
  • 6.6. Global 3D Bioprinting Market, Sub-Segmentation Of Bioinks, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Natural Bioinks
  • Synthetic Bioinks
  • Hybrid Bioinks
  • Hydrogels

7. 3D Bioprinting Market Regional And Country Analysis

  • 7.1. Global 3D Bioprinting Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global 3D Bioprinting Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific 3D Bioprinting Market

  • 8.1. Asia-Pacific 3D Bioprinting Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific 3D Bioprinting Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China 3D Bioprinting Market

  • 9.1. China 3D Bioprinting Market Overview
  • 9.2. China 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China 3D Bioprinting Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India 3D Bioprinting Market

  • 10.1. India 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India 3D Bioprinting Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan 3D Bioprinting Market

  • 11.1. Japan 3D Bioprinting Market Overview
  • 11.2. Japan 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan 3D Bioprinting Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia 3D Bioprinting Market

  • 12.1. Australia 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia 3D Bioprinting Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia 3D Bioprinting Market

  • 13.1. Indonesia 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia 3D Bioprinting Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea 3D Bioprinting Market

  • 14.1. South Korea 3D Bioprinting Market Overview
  • 14.2. South Korea 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea 3D Bioprinting Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe 3D Bioprinting Market

  • 15.1. Western Europe 3D Bioprinting Market Overview
  • 15.2. Western Europe 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe 3D Bioprinting Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK 3D Bioprinting Market

  • 16.1. UK 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK 3D Bioprinting Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany 3D Bioprinting Market

  • 17.1. Germany 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany 3D Bioprinting Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France 3D Bioprinting Market

  • 18.1. France 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France 3D Bioprinting Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy 3D Bioprinting Market

  • 19.1. Italy 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy 3D Bioprinting Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain 3D Bioprinting Market

  • 20.1. Spain 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain 3D Bioprinting Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe 3D Bioprinting Market

  • 21.1. Eastern Europe 3D Bioprinting Market Overview
  • 21.2. Eastern Europe 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe 3D Bioprinting Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia 3D Bioprinting Market

  • 22.1. Russia 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia 3D Bioprinting Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America 3D Bioprinting Market

  • 23.1. North America 3D Bioprinting Market Overview
  • 23.2. North America 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America 3D Bioprinting Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA 3D Bioprinting Market

  • 24.1. USA 3D Bioprinting Market Overview
  • 24.2. USA 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA 3D Bioprinting Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada 3D Bioprinting Market

  • 25.1. Canada 3D Bioprinting Market Overview
  • 25.2. Canada 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada 3D Bioprinting Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America 3D Bioprinting Market

  • 26.1. South America 3D Bioprinting Market Overview
  • 26.2. South America 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America 3D Bioprinting Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil 3D Bioprinting Market

  • 27.1. Brazil 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil 3D Bioprinting Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East 3D Bioprinting Market

  • 28.1. Middle East 3D Bioprinting Market Overview
  • 28.2. Middle East 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East 3D Bioprinting Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa 3D Bioprinting Market

  • 29.1. Africa 3D Bioprinting Market Overview
  • 29.2. Africa 3D Bioprinting Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa 3D Bioprinting Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa 3D Bioprinting Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. 3D Bioprinting Market Competitive Landscape And Company Profiles

  • 30.1. 3D Bioprinting Market Competitive Landscape
  • 30.2. 3D Bioprinting Market Company Profiles
    • 30.2.1. Organovo Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Allevi Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Cellink AB Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Aspect Biosystems Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. 3D Systems Corporation Overview, Products and Services, Strategy and Financial Analysis

31. 3D Bioprinting Market Other Major And Innovative Companies

  • 31.1. Cyfuse Biomedical KK
  • 31.2. EnvisionTEC GmbH
  • 31.3. Poietis SA
  • 31.4. TeVido BioDevices
  • 31.5. Nano3D Biosciences Inc.
  • 31.6. Digilab Inc.
  • 31.7. RegenHU Ltd.
  • 31.8. GeSiM mbH
  • 31.9. Advanced Solutions Life Sciences LLC
  • 31.10. Regenovo Biotechnology Co. Ltd.
  • 31.11. Regemat 3D S.L.
  • 31.12. Bio3D Technologies
  • 31.13. Stratasys Ltd.
  • 31.14. ROKIT Healthcare Co. Ltd.
  • 31.15. Inventia Life Science Pvt. Ltd.

32. Global 3D Bioprinting Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The 3D Bioprinting Market

34. Recent Developments In The 3D Bioprinting Market

35. 3D Bioprinting Market High Potential Countries, Segments and Strategies

  • 35.1 3D Bioprinting Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 3D Bioprinting Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 3D Bioprinting Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer